Brief: Precision Biosciences Announces Late-Breaking Oral Presentation For Pbgene-Hbv At Aasld The Liver Meeting® 2025
14/10/2025 12:13
Oct 14 (Reuters) - Precision BioSciences Inc DTIL.O: PRECISION BIOSCIENCES ANNOUNCES LATE-BREAKING ORAL PRESENTATION FOR PBGENE-HBV AT AASLD THE LIVER MEETING® 2025 Source text: ID:nBw2X9RYha Further company coverage: DTIL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precision Biosciences
See all newsPrecision BioSciences Inc reports results for the quarter ended June 30 - Earnings Summary
Precision BioSciences Q2 net loss widens on warrant liability charge
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Brief: Precision Biosciences - Enters First Amendment To Loan And Security Agreement With Banc Of California - SEC Filing